|
|
||||||||



Departments of
*
Immunology and
Neurology, Mayo Clinic, Rochester, MN 55905; and
Department of Neurology, University of Chicago Medical Center, Chicago, IL 66906
In susceptible mouse strains, the wild-type Daniels (wt-DA) strain of Theilers murine encephalomyelitis virus induces a persistent central nervous system (CNS) infection with chronic demyelination. The virus is cleared from resistant mice with no resulting demyelination. We characterized the role of the DA L* protein in late demyelination and persistent infection. The DA genome has two alternative reading frames, encoding the virus polyprotein and L*, respectively. The mutant virus DAL*-1 fails to synthesize L* and does not persist in the CNS of wt-DA-susceptible SJL/J or B10.S mice. Since class I-restricted cytotoxicity has been shown to determine resistance to virus persistence and demyelination in this model, virus-specific cytotoxicity in the CNS of DA-resistant (B6 or B10) and -susceptible (SJL/J and B10.S) mice during the acute stage of DA and DAL*-1 infection was characterized. Following intracerebral inoculation with DAL*-1, virus-specific Db- and Kb-restricted CTLs were demonstrated in the CNS of resistant B10 mice, whereas only Db-restricted CTL were found in wt-DA-inoculated mice. CTLs specific to wt-DA or DAL*-1 recognized class I-presented peptides from either of the viruses. Of particular interest, Ks-restricted virus-specific cytotoxicity-restricted CTLs were identified in the CNS of susceptible SJL/J (H-2s) and B10.S (H-2s) mice inoculated with DAL*-1. In contrast, no virus-specific CTLs were identified in the CNS of SJL/J and B10.S mice inoculated with wt-DA. We propose that L* inhibits the generation of H-2K-restricted virus-specific cytotoxicity in the CNS, permitting a persistent infection in susceptible strains, with subsequent inflammatory demyelination in the CNS similar to that in human multiple sclerosis.
This article has been cited by other articles:
![]() |
X. Lin, X. Ma, M. Rodriguez, and R. P. Roos CD4+ T cells are important for clearance of DA strain of TMEV from the central nervous system of SJL/J mice Int. Immunol., September 1, 2004; 16(9): 1237 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Oleszak, J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas Theiler's Virus Infection: a Model for Multiple Sclerosis Clin. Microbiol. Rev., January 1, 2004; 17(1): 174 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Lin, X. Ma, M. Rodriguez, X. Feng, L. Zoecklein, Y.-X. Fu, and R. P. Roos Membrane lymphotoxin is required for resistance to Theiler's virus infection Int. Immunol., August 1, 2003; 15(8): 955 - 962. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Asakura, H. Murayama, T. Himeda, and Y. Ohara Epitope-Tagged L* Protein of Theiler's Murine Encephalomyelitis Virus Is Expressed in the Central Nervous System in the Acute Phase of Infection J. Virol., November 13, 2002; 76(24): 13049 - 13054. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. van Eyll and T. Michiels Non-AUG-Initiated Internal Translation of the L* Protein of Theiler's Virus and Importance of This Protein for Viral Persistence J. Virol., October 2, 2002; 76(21): 10665 - 10673. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-S. Kang, M. A. Lyman, and B. S. Kim The Majority of Infiltrating CD8+ T Cells in the Central Nervous System of Susceptible SJL/J Mice Infected with Theiler's Virus Are Virus Specific and Fully Functional J. Virol., June 5, 2002; 76(13): 6577 - 6585. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Murray, D. B. McGavern, S. Sathornsumetee, and M. Rodriguez Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosis Brain, July 1, 2001; 124(7): 1403 - 1416. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Deitz, D. A. Dodd, S. Cooper, P. Parham, and K. Kirkegaard MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A PNAS, November 22, 2000; (2000) 250483097. [Abstract] [Full Text] |
||||
![]() |
O. van Eyll and T. Michiels Influence of the Theiler's Virus L* Protein on Macrophage Infection, Viral Persistence, and Neurovirulence J. Virol., October 1, 2000; 74(19): 9071 - 9077. [Abstract] [Full Text] |
||||
![]() |
M. Obuchi, J. Yamamoto, T. Odagiri, M. N. Uddin, H. Iizuka, and Y. Ohara L* Protein of Theiler's Murine Encephalomyelitis Virus Is Required for Virus Growth in a Murine Macrophage-Like Cell Line J. Virol., May 15, 2000; 74(10): 4898 - 4901. [Abstract] [Full Text] |
||||
![]() |
K. Yamasaki, C. C. Weihl, and R. P. Roos Alternative Translation Initiation of Theiler's Murine Encephalomyelitis Virus J. Virol., October 1, 1999; 73(10): 8519 - 8526. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Johnson, M. K. Njenga, M. J. Hansen, S. T. Kuhns, L. Chen, M. Rodriguez, and L. R. Pease Prevalent Class I-Restricted T-Cell Response to the Theiler's Virus Epitope Db:VP2121-130 in the Absence of Endogenous CD4 Help, Tumor Necrosis Factor Alpha, Gamma Interferon, Perforin, or Costimulation through CD28 J. Virol., May 1, 1999; 73(5): 3702 - 3708. [Abstract] [Full Text] |
||||
![]() |
S. B. Deitz, D. A. Dodd, S. Cooper, P. Parham, and K. Kirkegaard MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A PNAS, December 5, 2000; 97(25): 13790 - 13795. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |